×
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13

ICU Medical Stock Forecast, Price & News

$168.21
+3.82 (+2.32%)
(As of 07/1/2022 03:59 PM ET)
Add
Compare
Today's Range
$163.98
$168.70
50-Day Range
$161.40
$218.69
52-Week Range
$158.60
$282.00
Volume
4,432 shs
Average Volume
206,198 shs
Market Capitalization
$4.02 billion
P/E Ratio
82.46
Dividend Yield
N/A
Price Target
$272.50

ICU Medical MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
62.0% Upside
$272.50 Price Target
Short Interest
Healthy
3.31% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.47
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
Selling Shares
$167.18 K Sold Last Quarter
Proj. Earnings Growth
21.88%
From $7.68 to $9.36 Per Share

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

2.64 out of 5 stars

Medical Sector

55th out of 1,412 stocks

Surgical & Medical Instruments Industry

8th out of 136 stocks

30 days | 90 days | 365 days | Advanced Chart

Receive ICUI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ICU Medical and its competitors with MarketBeat's FREE daily newsletter.

ICU Medical logo

About ICU Medical (NASDAQ:ICUI) Stock

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and SwabTip disinfecting caps; Tego hemodialysis connectors; ClearGuard HD, an antimicrobial barrier cap for hemodialysis catheters; and ChemoClave and ChemoLock closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs. It also provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. The company offers infusion pumps under the Plum 360 and LifeCare PCA brands; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform that connects smart pumps to hospital's electronic health records, asset tracking systems, and alarm notification platforms; and related professional services. It also provides critical care products, such as Cogent 2-in-1 and CardioFlo hemodynamic monitoring systems; TDQ and OptiQ cardiac output monitoring catheters; TriOx venous oximetry catheters; Transpac blood pressure transducers; and SafeSet closed blood sampling and conservation systems. The company sells its products to acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California.

ICUI Stock News Headlines

ICU Medical is Now Oversold (ICUI)
ICU Medical Q1 Earnings Summary
ICU Medical Tops Q1 EPS by 4c
ICU Medical Announces First Quarter 2022 Results
2 Medical Device Stocks That are Screaming Buys
ICU Medical: Q4 Earnings Snapshot
See More Headlines

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Supplies
Sector
Medical
Current Symbol
NASDAQ:ICUI
CUSIP
44930G10
Employees
8,500
Year Founded
1984

Company Calendar

Last Earnings
5/09/2022
Today
7/04/2022
Next Earnings (Estimated)
8/03/2022
Fiscal Year End
12/31/2022

Price Target and Rating

Average Stock Price Forecast
$272.50
High Stock Price Forecast
$280.00
Low Stock Price Forecast
$265.00
Forecasted Upside/Downside
+62.0%
Consensus Rating
Buy
Rating Score (0-4)
3
Research Coverage
2 Analysts

Profitability

Net Income
$103.14 million
Pretax Margin
2.68%

Debt

Sales & Book Value

Annual Sales
$1.32 billion
Cash Flow
$10.55 per share
Book Value
$76.09 per share

Miscellaneous

Free Float
22,152,000
Market Cap
$4.02 billion
Optionable
Optionable
Beta
0.53

Social Links















ICU Medical Frequently Asked Questions

Should I buy or sell ICU Medical stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for ICU Medical in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ICU Medical stock.
View analyst ratings for ICU Medical
or view top-rated stocks.

What is ICU Medical's stock price forecast for 2022?

2 Wall Street research analysts have issued 12 month price targets for ICU Medical's shares. Their ICUI stock forecasts range from $265.00 to $280.00. On average, they predict ICU Medical's share price to reach $272.50 in the next year. This suggests a possible upside of 62.0% from the stock's current price.
View analysts' price targets for ICU Medical
or view top-rated stocks among Wall Street analysts.

How has ICU Medical's stock price performed in 2022?

ICU Medical's stock was trading at $237.34 at the beginning of the year. Since then, ICUI stock has decreased by 29.1% and is now trading at $168.21.
View the best growth stocks for 2022 here
.

When is ICU Medical's next earnings date?

ICU Medical is scheduled to release its next quarterly earnings announcement on Wednesday, August 3rd 2022.
View our earnings forecast for ICU Medical
.

How were ICU Medical's earnings last quarter?

ICU Medical, Inc. (NASDAQ:ICUI) released its quarterly earnings data on Monday, May, 9th. The medical instruments supplier reported $1.32 EPS for the quarter, missing analysts' consensus estimates of $1.53 by $0.21. The medical instruments supplier had revenue of $543.10 million for the quarter, compared to the consensus estimate of $557.33 million. ICU Medical had a trailing twelve-month return on equity of 7.89% and a net margin of 2.68%. The business's quarterly revenue was up 70.8% compared to the same quarter last year. During the same period last year, the business earned $1.34 earnings per share.
View ICU Medical's earnings history
.

Who are ICU Medical's key executives?

ICU Medical's management team includes the following people:
  • Mr. Vivek Jain, CEO & Chairman (Age 50, Pay $1.31M)
  • Mr. Brian Michael Bonnell, CFO & Treasurer (Age 48, Pay $645.5k)
  • Mr. Christian B. Voigtlander, Chief Operating Officer (Age 53, Pay $685.5k)
  • Ms. Virginia Ruth Sanzone, Corp. VP, Gen. Counsel, Sec. & Compliance Officer (Age 47, Pay $523.5k) (LinkedIn Profile)

What is Vivek Jain's approval rating as ICU Medical's CEO?

81 employees have rated ICU Medical CEO Vivek Jain on Glassdoor.com. Vivek Jain has an approval rating of 73% among ICU Medical's employees.

What other stocks do shareholders of ICU Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ICU Medical investors own include Becton, Dickinson and (BDX), BlackRock (BLK), NVIDIA (NVDA), Alibaba Group (BABA), CA (CA), UnitedHealth Group (UNH), Boeing (BA), Micron Technology (MU), Lockheed Martin (LMT) and ServiceNow (NOW).

What is ICU Medical's stock symbol?

ICU Medical trades on the NASDAQ under the ticker symbol "ICUI."

How do I buy shares of ICU Medical?

Shares of ICUI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ICU Medical's stock price today?

One share of ICUI stock can currently be purchased for approximately $168.21.

How much money does ICU Medical make?

ICU Medical (NASDAQ:ICUI) has a market capitalization of $4.02 billion and generates $1.32 billion in revenue each year. The medical instruments supplier earns $103.14 million in net income (profit) each year or $2.04 on an earnings per share basis.

How many employees does ICU Medical have?

ICU Medical employs 8,500 workers across the globe.

When was ICU Medical founded?

ICU Medical was founded in 1984.

How can I contact ICU Medical?

ICU Medical's mailing address is 951 CALLE AMANECER, SAN CLEMENTE CA, 92763. The official website for ICU Medical is www.icumed.com. The medical instruments supplier can be reached via phone at (949) 366-2183, via email at ir@icumed.com, or via fax at 949-366-8368.

This page (NASDAQ:ICUI) was last updated on 7/4/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.